Embecta Corp. (EMBC)
NASDAQ: EMBC · Real-Time Price · USD
10.91
-0.03 (-0.27%)
At close: Feb 3, 2026, 4:00 PM EST
10.91
0.00 (0.00%)
After-hours: Feb 3, 2026, 4:10 PM EST
Embecta Market Cap
Embecta has a market cap or net worth of $646 million as of February 3, 2026. Its market cap has decreased by -40.92% in one year.
Market Cap
646.00M
Enterprise Value
1.87B
1-Year Change
-40.92%
Ranking
Category
Stock Price
$10.91
Market Cap Chart
Since March 22, 2022, Embecta's market cap has decreased from $2.68B to $646.00M, a decrease of -75.86%. That is a compound annual growth rate of -30.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 647.78M | -7.91% |
| Dec 31, 2025 | 703.44M | -41.40% |
| Dec 31, 2024 | 1.20B | 10.14% |
| Dec 29, 2023 | 1.09B | -24.67% |
| Dec 30, 2022 | 1.45B | -45.94% |
| Mar 22, 2022 | 2.68B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AtriCure | 1.84B |
| Azenta | 1.79B |
| Kestra Medical Technologies | 1.44B |
| BioLife Solutions | 1.05B |
| Anbio Biotechnology | 961.66M |
| STAAR Surgical Company | 942.61M |
| Pulse Biosciences | 937.23M |
| Anteris Technologies Global | 601.11M |